Author:
Greenwald Mark K.,Comer Sandra D.,Fiellin David A.
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology
Reference106 articles.
1. Bringing buprenorphine–naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience;Amass;Am. J. Addict.,2004
2. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals;Amass;Addiction,2012
3. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis;Bertalmio;J. Pharmacol. Exp. Ther.,1987
4. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis;Bertalmio;J. Pharmacol. Exp. Ther.,1989
5. Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients;Bickel;Psychopharmacology (Berl.),1999
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献